Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Sleep is impaired in patients with CIDP and contributes to the overall disease burden. Our findings suggest that sleep disturbances can be tracked longitudinally using smartwatch-derived markers. Integrating digital health data presents promising opportunities for long-term sleep monitoring in this population. Larger studies, ideally incorporating polysomnography, are warranted to validate these findings.
Authors
- Nikos Werner (ORCID: https://orcid.org/0000-0003-1331-882X)
- Sven Guenther Meuth (ORCID: https://orcid.org/0000-0003-2571-3501)
- Lars Masanneck (ORCID: https://orcid.org/0000-0003-2496-1415)
- Gerd Meyer zu Hörste (ORCID: https://orcid.org/0000-0002-4341-4719)
- Marc Pawlitzki (ORCID: https://orcid.org/0000-0003-3080-2277)
- Charlotte von Gall (ORCID: https://orcid.org/0000-0002-5088-3118)
- Jan Voth
- Noemi Gmahl
Institutions
- Hasso Plattner Institute (DE)
- Düsseldorf University Hospital (DE)
- University Hospital Münster (DE)
- Heinrich Heine University Düsseldorf (DE)
Publication Details
- Journal
- Journal of the Peripheral Nervous System
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1111/jns.70069
- Citations
- 1
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Alexion Pharmaceuticals
- Celgene
- B. Braun-Stiftung
- Amicus Therapeutics
- Fresenius Medical Care North America
- Argenx
- Deutscher Akademischer Austauschdienst
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Novo Nordisk
- Deutschen Multiple Sklerose Gesellschaft
- Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
- Neuraxpharm
- Gemeinsame Bundesausschuss
- MedDay Pharmaceuticals
- Chugai Pharmaceutical
- Bundesinstitut für Risikobewertung